wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55192756-FC728FD1-B436-4FE9-A592-E72E710A8F62
Q55192756-FC728FD1-B436-4FE9-A592-E72E710A8F62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55192756-FC728FD1-B436-4FE9-A592-E72E710A8F62
Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment.
P2860
Q55192756-FC728FD1-B436-4FE9-A592-E72E710A8F62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55192756-FC728FD1-B436-4FE9-A592-E72E710A8F62
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
79904b51aaccc69fdcbc43134648cccc4b5c21bd
P2860
Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.